Abstract
Migraine is a common headache disorder with significant impact on quality of life. Despite the significant progress in treatment and understanding of migraine, the care of sufferers is inadequate in low resource settings. Studies on characteristics of migraine patients receiving care in sub-Saharan Africa are limited. We aim to determine the effect of demographic characteristics on migraine diagnosis, and the adequacy of treatment offered in tertiary hospitals. This was a multi-centre, hospital-based, cross-sectional study conducted over 4 months in Northeast Nigeria. Participants were patients with known migraine on follow up at the neurology outpatient clinics. The sociodemographic, clinical records, and treatment outcome of each subject was documented. Of the 112 migraineurs who fulfilled the inclusion criteria, 104 consented to participate in the study. The mean age of the participants was 30.8 ± 10.4 years. Females constituted 74% of subjects, with a female to male ratio of 2.9:1. The difference between the mean age of migraine onset and the mean age at diagnosis was 4.6 years. On multivariate logistic regression analysis, age at headache onset (p = 0.001) and lower level of education (p = 0.03) independently predicted a delay in diagnosis of migraine. At first specialist clinic visit, 69.2% of the subjects had only a diagnosis of chronic migraine, 25% was additionally diagnosed with medication overuse headache, and about 92% was not placed on migraine preventive medication for their headaches despite meeting the criteria. Fifty-five (52.9%) patients had clinic visits in the past 12 months, among which prophylactic medications were used by 26 (45.1%) patients, while 13 (23.6%) were not adherent to preventive drug treatment, and 16 (29%) patients used their preventive medications as acute treatment. The significant delay from headache onset to migraine diagnosis has resulted in a more prevalent presentation with chronic migraine headache. Younger age at migraine onset and low educational attainment may affect diagnosis and treatment. The low prescription rate of migraine prophylactic medications by practitioners in this region may be affecting the quality of life of migraineurs.
Similar content being viewed by others
References
Charles A. clinical practice. N Engl J Med. 2017;377:553–61.
Onwueke I, Onyeka T, Aguwa E, Ezeala-Adakaibe B, Ekenze O, Onuora E. headache prevalence and its characterization amongst hospital workers in Enugu, South East Nigeria. Head Face Med. 2014;10:48.
Ojini FI, Okubadejo N, Danesi MA. Prevalence and clinical characteristics of headache in medical students of the university of Lagos, Nigeria. Cephalagia. 2008;29:472–7.
Zebenigus M, Tekle-Haimont R, Worku DK, Thomas H, Steiner TJ. The prevalence of primary headache disorders in Ethiopia. J Headache Pain. 2016;17:110.
Oshinaike O, Ojo O, Okubadejo N, Ojelabi O, Dada A. Primary headache disorders at a tertiary health facility in Lagos, Nigeria: prevalence and consultation pattern. Biomed Res Int. 2014;782915. https://doi.org/10.1155/2014/782915
Mbewe E, Zairemthiama P, Yeh H, Paul R, Birbeck G, Steiner TJ. The epidemiology of primary headache disorders in Zambia: a population based door-to-door survey. J Head Face Pain. 2015;16:30.
Balarabe SA, Yunusa MA. Prevalence of migraine among medical students in Sokoto, northwestern Nigeria. Eur J Pharm Med Res. 2016;3(12):604–8.
Takeshima T, Wan Q, Zhan Y, Komori M, Stretton S, Rajan N, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain. 2019;20:111.
Hagen K, Stovner LJ, Zwart JA. Time trends of major headache diagnosis and predictive factors. Data from three Nord-Trøndelag health surveys. J Headache Pain. 2020;21:24.
Luvsannorov O, Tsenddorj B, Baldorj D, Enkhtuya S, Purev D, Thomas H, et al. Primary headache disorders among the adult population of Mongolia: prevalence and associations from a population-based survey. J Headache Pain. 2019;20:114.
Al Jumah M, Al khataami AM, Kojan S, Hussain M, Thomas H, Steiner TJ. The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study. J Headache Pain. 2020;21:11.
Xie W, Li R, He M, Cui F, Sun T, Xiong J, et al. Prevalence and risk factors associated with headache amongst medical staff in South China. J Headache Pain. 2020;21:5.
Genc D, Vaičienė-Magistris N, Zaborskis A, Şaşmaz T, Tunç AY, Uluduz D, et al. the prevalence of headache disorders in children and adolescents in Lithuania: a school-based study. J Headache Pain. 2020;21:73.
Herpole LH, Samsa GP, Matcha DB, Silberstein SD, Blumenfeld A, Jurgelski AE. Burden of illness and satisfaction with care among patient seen in a primary care setting. Headache. 2005;45:1048–55.
Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe-evidence from Eurolight study. J Headache Pain. 2018;19(1):10.
The International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2002;24:1–160.
Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, et al. Sex difference in the prevalence, symptoms and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53:1278–99.
Adam VY, Aigbokhoade AQ. Sociodemographic factors associated with the healthcare seeking behaviour of heads of households in a rural community in southern Nigeria. Sahel Med J. 2018;21:31–6.
Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting the Burden: the Global Campaign against Headache. J Headache Pain. 2019;20:57.
Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, et al. Primary headache disorders I republic of Georgia: prevalence and risk factors. Neurology. 2009;73:1796–803.
Ofovwe GE, Ofili AN. Prevalence and impact of headache and migraine among secondary school students in Nigeria. Headache. 2010;50:1570–5.
Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, et al. Time delay from onset to diagnosis of migraine. Headache. 2011;51:232–6.
Alzahrani F, Hmoud M, Farahat F, Manlagit J, Alghattani HA, Attar A. Knowledge of primary health-care physician about headache disorders: a cross-sectional study. Qual Prim Care. 2016;24:83–6.
Davies PTG, Lane RJM, Fontebasso M, Murphy J, Matharu M. The long and winding road: the journey taken by headache sufferers in search of help. Prim Health Care Res Dev. 2018;20:1–6.
Lanteri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life and acute migraine management. Pain. 2005;118:319–26.
Adams AM, Serrano D, Buse DC, Reed ML, Valerie M, Fanning KM, et al. The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Cephalalgia. 2015;35:563–78.
Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14(1):1.
Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2014;0:1–11.
Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm. 2014;20:22–33.
Acknowledgements
The authors appreciate the efforts of nurses, medical record officers, and other ad hoc staffs of their respective institutions.
Authors' Contributions
MWA, UBM, FKS, YAA, and AOK participated in data acquisition, data interpretation, and manuscript editing, and preparation were done by MWA and CO. MAW and MAD participated in data analysis. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
Approval for the study was obtained from the ethics and research committee of the respective institutions prior to commencement of the study. The research was performed in accordance with the Declaration of Helsinki.
Consent to Participate
All participants gave informed consent before taking part in the study.
Consent for Publication
All authors agreed on decision to publish this manuscript.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Ali, M.W., Musami, U.B., Sa’ad, F.K. et al. Profile of Migraine Patients in a Developing Country: a Multicentre Study. SN Compr. Clin. Med. 2, 1153–1157 (2020). https://doi.org/10.1007/s42399-020-00394-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-020-00394-x